Reach Resources Limited (ASX: RR1 & RR1O) (“Reach” or “the Company”) is pleased to announce…
Category:
Investing
-
-
-
Investing
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
by adminDSMC concluded that Phase 1 study may continue as planned without any modifications On track…
-
-
-
-
-
-
-
Investing
Group Eleven Intersects 12.0m of 2.30% Cu and 560 g/t Ag, Including 6.4m of 3.72% Cu and 838 g/t Ag, Demonstrating High-Grade Copper and Silver Potential at Ballywire
by adminGroup Eleven Resources Corp. (TSXV: ZNG) (OTC Pink: GRLVF) (FSE: 3GE) (‘Group Eleven’ or the…